XIFAXAN (rifaximin)
RIFAMYCINS · DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
SALIX/BAUSCH HE
Drug class
Antibiotics for Hyperammonemia
While not a formal regulatory drug class established by the FDA, "antibiotics for hyperammonemia" is a functional clinical grouping of gut-active antimicrobial agents, primarily rifaximin and historically neomycin, employed to manage elevated blood ammonia levels. Read more about Antibiotics for Hyperammonemia
8 drugs in this class 8 manufacturers
Drugs in Antibiotics for Hyperammonemia
XIFAXAN (rifaximin)
RIFAMYCINS · DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
SALIX PHARMACEU
NEOMYCIN SULFATE
ORAL AMINOGLYCOSIDES · PREOPERATIVE BOWEL PREPARATION ·+2
X-GEN PHARMACEU
NEOMYCIN SULFATE
ORAL AMINOGLYCOSIDES · PREOPERATIVE BOWEL PREPARATION ·+2
TEVA USA
XIFAXAN (rifaximin)
RIFAMYCINS · DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
A-S MEDICATION
XIFAXAN (rifaximin)
RIFAMYCINS · DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
CARDINAL HEALTH
NEOMYCIN SULFATE
ORAL AMINOGLYCOSIDES · PREOPERATIVE BOWEL PREPARATION ·+2
CHARTWELL RX LL
NEOMYCIN SULFATE
ORAL AMINOGLYCOSIDES · PREOPERATIVE BOWEL PREPARATION ·+2
SOLARIS PHARMA
Filter & compare in the drug finder →
Opens the drug finder with Antibiotics for Hyperammonemia preselected. Add indication or manufacturer filters there.
While not a formal regulatory drug class established by the FDA, "antibiotics for hyperammonemia" is a functional clinical grouping of gut-active antimicrobial agents, primarily rifaximin and historically neomycin, employed to manage elevated blood ammonia levels.
These agents work predominantly within the gastrointestinal lumen to suppress the proliferation of urease-producing enteric bacteria, thereby reducing the bacterial breakdown of urea and protein into ammonia and limiting its systemic absorption.
This therapeutic strategy is primarily utilized in the management of hepatic encephalopathy secondary to cirrhosis or acute-on-chronic liver disease, typically as an adjunct or alternative to nonabsorbable disaccharides.
-
fda.gov
While not a formal regulatory drug class established by the FDA, "antibiotics for hyperammonemia" is a functional clinical grouping of gut-active antimicrobial agents, primarily rifaximin and historically neomycin, employed to manage elevated blood ammonia levels These agents work predominantly within the gastrointestinal lumen to suppress the proliferation of urease-producing enteric bacteria, thereby reducing the bacterial breakdown of urea and protein into ammonia and limiting its systemic ab...
-
nih.gov
While not a formal regulatory drug class established by the FDA, "antibiotics for hyperammonemia" is a functional clinical grouping of gut-active antimicrobial agents, primarily rifaximin and historically neomycin, employed to manage elevated blood ammonia levels These agents work predominantly within the gastrointestinal lumen to suppress the proliferation of urease-producing enteric bacteria, thereby reducing the bacterial breakdown of urea and protein into ammonia and limiting its systemic ab...
-
nih.gov
This therapeutic strategy is primarily utilized in the management of hepatic encephalopathy secondary to cirrhosis or acute-on-chronic liver disease, typically as an adjunct or alternative to nonabsorbable disaccharides
-
ajmc.com
This therapeutic strategy is primarily utilized in the management of hepatic encephalopathy secondary to cirrhosis or acute-on-chronic liver disease, typically as an adjunct or alternative to nonabsorbable disaccharides
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.